103 related articles for article (PubMed ID: 34391775)
1. EPS8 supports pancreatic cancer growth by inhibiting BMI1 mediated proteasomal degradation of ALDH7A1.
Tan M; Meng J; Sun X; Fu X; Wang R
Exp Cell Res; 2021 Oct; 407(1):112782. PubMed ID: 34391775
[TBL] [Abstract][Full Text] [Related]
2. Overall survival of pancreatic ductal adenocarcinoma is doubled by
Lee JS; Lee H; Woo SM; Jang H; Jeon Y; Kim HY; Song J; Lee WJ; Hong EK; Park SJ; Han SS; Kim SY
Theranostics; 2021; 11(7):3472-3488. PubMed ID: 33537098
[No Abstract] [Full Text] [Related]
3. Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.
Chen SJ; Chen YT; Zeng LJ; Zhang QB; Lian GD; Li JJ; Yang KG; Huang CM; Li YQ; Chu ZH; Huang KH
Tumour Biol; 2016 Aug; 37(8):11299-309. PubMed ID: 26951514
[TBL] [Abstract][Full Text] [Related]
4. The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma.
Martínez-Romero C; Rooman I; Skoudy A; Guerra C; Molero X; González A; Iglesias M; Lobato T; Bosch A; Barbacid M; Real FX; Hernández-Muñoz I
J Pathol; 2009 Oct; 219(2):205-13. PubMed ID: 19585519
[TBL] [Abstract][Full Text] [Related]
5. Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells.
Benitz S; Regel I; Reinhard T; Popp A; Schäffer I; Raulefs S; Kong B; Esposito I; Michalski CW; Kleeff J
Oncotarget; 2016 Mar; 7(10):11424-33. PubMed ID: 26716510
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteomic analysis identifies exosomal Eps8 protein as a potential metastatic biomarker for pancreatic cancer.
Ohshima K; Hatakeyama K; Kanto K; Ide T; Watanabe Y; Moromizato S; Wakabayashi-Nakao K; Sakura N; Yamaguchi K; Mochizuki T
Oncol Rep; 2019 Feb; 41(2):1019-1034. PubMed ID: 30431134
[TBL] [Abstract][Full Text] [Related]
7. lncRNA
Li N; Yang G; Luo L; Ling L; Wang X; Shi L; Lan J; Jia X; Zhang Q; Long Z; Liu J; Hu W; He Z; Liu H; Liu W; Zheng G
Clin Cancer Res; 2020 Apr; 26(7):1736-1748. PubMed ID: 31831555
[TBL] [Abstract][Full Text] [Related]
8. Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism.
Bednar F; Schofield HK; Collins MA; Yan W; Zhang Y; Shyam N; Eberle JA; Almada LL; Olive KP; Bardeesy N; Fernandez-Zapico ME; Nakada D; Simeone DM; Morrison SJ; Pasca di Magliano M
Carcinogenesis; 2015 Jul; 36(7):730-8. PubMed ID: 25939753
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
10.
Umbreen S; Banday MM; Jamroze A; Mansini AP; Ganaie AA; Ferrari MG; Maqbool R; Beigh FH; Murugan P; Morrissey C; Corey E; Konety BR; Saleem M
Mol Cancer Ther; 2019 Nov; 18(11):2111-2123. PubMed ID: 31467179
[TBL] [Abstract][Full Text] [Related]
11. Eps8 is increased in pancreatic cancer and required for dynamic actin-based cell protrusions and intercellular cytoskeletal organization.
Welsch T; Endlich K; Giese T; Büchler MW; Schmidt J
Cancer Lett; 2007 Oct; 255(2):205-18. PubMed ID: 17537571
[TBL] [Abstract][Full Text] [Related]
12. High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway.
Duan Q; Li H; Gao C; Zhao H; Wu S; Wu H; Wang C; Shen Q; Yin T
J Exp Clin Cancer Res; 2019 May; 38(1):192. PubMed ID: 31088566
[TBL] [Abstract][Full Text] [Related]
13. Gene regulation by antitumor miR-130b-5p in pancreatic ductal adenocarcinoma: the clinical significance of oncogenic EPS8.
Fukuhisa H; Seki N; Idichi T; Kurahara H; Yamada Y; Toda H; Kita Y; Kawasaki Y; Tanoue K; Mataki Y; Maemura K; Natsugoe S
J Hum Genet; 2019 Jun; 64(6):521-534. PubMed ID: 30858505
[TBL] [Abstract][Full Text] [Related]
14. The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target.
Alchanati I; Teicher C; Cohen G; Shemesh V; Barr HM; Nakache P; Ben-Avraham D; Idelevich A; Angel I; Livnah N; Tuvia S; Reiss Y; Taglicht D; Erez O
PLoS One; 2009 Dec; 4(12):e8104. PubMed ID: 19956605
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma.
Dang Z; Xu WH; Lu P; Wu N; Liu J; Ruan B; Zhou L; Song WJ; Dou KF
Int J Biol Sci; 2014; 10(7):733-45. PubMed ID: 25013381
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Regulation of Bmi1 by Ubiquitination and Proteasomal Degradation Inhibit Bcl-2 in Acute Myeloid Leukemia.
Kushwaha AC; Mohanbhai SJ; Sardoiwala MN; Sood A; Karmakar S; Roy Choudhury S
ACS Appl Mater Interfaces; 2020 Jun; 12(23):25633-25644. PubMed ID: 32453568
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 7A1 (ALDH7A1) is a novel enzyme involved in cellular defense against hyperosmotic stress.
Brocker C; Lassen N; Estey T; Pappa A; Cantore M; Orlova VV; Chavakis T; Kavanagh KL; Oppermann U; Vasiliou V
J Biol Chem; 2010 Jun; 285(24):18452-63. PubMed ID: 20207735
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 7A1 (ALDH7A1) attenuates reactive aldehyde and oxidative stress induced cytotoxicity.
Brocker C; Cantore M; Failli P; Vasiliou V
Chem Biol Interact; 2011 May; 191(1-3):269-77. PubMed ID: 21338592
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma.
Singh S; Arcaroli JJ; Orlicky DJ; Chen Y; Messersmith WA; Bagby S; Purkey A; Quackenbush KS; Thompson DC; Vasiliou V
Pancreas; 2016 Jan; 45(1):117-22. PubMed ID: 26566217
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory short peptides targeting EPS8/ABI1/SOS1 tri-complex suppress invasion and metastasis of ovarian cancer cells.
Yu X; Liang C; Zhang Y; Zhang W; Chen H
BMC Cancer; 2019 Sep; 19(1):878. PubMed ID: 31488087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]